The use of tocainide, encainide, lorcainide and flecainide for supraventricular arrhythmias.
D000813:Anilides / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D001281:Atrial Fibrillation / Q000188:drug therapy; D001283:Atrioventricular Node; D044482:Benzeneacetamides; D016700:Encainide; D005424:Flecainide; D006325:Heart Atria; D006801:Humans; D008012:Lidocaine / Q000031:analogs & derivatives / Q000627:therapeutic use; D010880:Piperidines / Q000627:therapeutic use; D013610:Tachycardia / Q000188:drug therapy; D016677:Tocainide; D014927:Wolff-Parkinson-White Syndrome / Q000188:drug therapy
D000813:Anilides; D000889:Anti-Arrhythmia Agents; D044482:Benzeneacetamides; D010880:Piperidines; D016677:Tocainide; D008012:Lidocaine; D005424:Flecainide; C015970:lorcainide; D016700:Encainide